Precision medicine study for advanced or returning colon cancer
Part of Cancer, Digestive system clinical trials.
This trial studies personalized (precision) treatment decisions for people with advanced or recurrent colorectal cancer. It aims to improve outcomes while carefully monitoring safety and how well the plan fits each participant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 75 years old
- You have confirmed advanced or returning colon/rectal cancer based on lab testing of a tissue or cell sample
- Your overall health for daily activities is good (ECOG 0 to 1) and you’re expected to live at least 3 months
- You can and will use effective birth control if you could become pregnant (or you are not able to have children), starting now and for 3 months after the last study dose
- You can understand the study and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if matching treatments to your tumor's genetic markers can help slow down metastatic colorectal cancer. You'll get a biopsy and blood draw to guide your therapy.
This trial grows a lab model from your own tumor tissue (or resected tissue) to predict which drugs might work best. It’s meant to match investigational treatments to your specific tumor biology.
This trial tests whether using a personalized approach (matching your tumor's genetic profile to a targeted drug) can help people with advanced solid cancers live longer. It is for people whose cancer is not responding to standard treatments and who have a genetic change that can be targeted by an FDA-approved drug not usually used for their cancer type.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
Hear when a new Advanced Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.